Suven Pharmaceuticals Ltd Annually Results

Gross Sales

1,051.35

1,340.33

1,320.22

1,009.72

833.79

Excise Duty

0

0

0

0

0

Net Sales

1,051.35

1,340.33

1,320.22

1,009.72

833.79

Other Operating Income

0

0

0

0

0

Other Income

61.91

46.36

133.49

67.97

66.33

Total Income

1,113.26

1,386.69

1,453.71

1,077.69

900.12

Total Expenditure

645.54

766.17

740.8

569.24

452.19

PBIDT

467.72

620.53

712.92

508.45

447.93

Interest

7.45

12.81

6.23

9.14

19.92

PBDT

460.27

607.72

706.69

499.31

428.02

Depreciation

54.6

47.99

39.1

31.64

23.51

Minority Interest Before NP

0

0

0

0

0

Tax

98.8

144.1

190.4

101.72

88.81

Deferred Tax

6.59

4.34

23.38

3.62

-1.3

Reported Profit After Tax

300.28

411.29

453.8

362.34

317

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

300.28

411.29

453.8

362.34

317

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

300.28

411.29

453.8

362.34

317

EPS (Unit Curr.)

11.8

16.16

17.83

14.23

24.91

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

600

500

200

500

Equity

25.46

25.46

25.46

25.46

12.73

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

44.48

46.29

54

50.35

53.72

PBDTM(%)

43.77

45.34

53.52

49.45

51.33

PATM(%)

28.56

30.68

34.37

35.88

38.01